Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure

Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure

Objective. To explore the application value of N-terminal pro-B type natriuretic peptide (NT-proBNP) combined with neutrophil-to-lymphocyte ratio (NLR) in evaluation of major adverse cardiac events (MACEs) in elderly patients with chronic heart failure (CHF). Methods. 50 CHF patients admitted to the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhiyong Li, Hui Rong, Wenxun Wu, Ting Huang, Jun Xu
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Emergency Medicine International
Online Access:	http://dx.doi.org/10.1155/2022/3689445
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NT-proBNP, Cardiometabolic Risk Factors, and Nutritional Status in Hemodialysis Patients
by: Jacques Ducros, et al.
Published: (2017-01-01)

Association between NT-proBNP Level and the Severity of COVID-19 Pneumonia
by: Lan Wang, et al.
Published: (2021-01-01)

High-sensitive cardiac troponin T and NT-proBNP are associated with the left ventricular apical thickness in apical hypertrophic cardiomyopathy
by: Meng Zhang, et al.
Published: (2025-01-01)

NT‐ProBNP and high‐sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population
by: Maria Averina, et al.
Published: (2022-06-01)

NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
by: Zuoan Qin, et al.
Published: (2021-01-01)

Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study
by: Liu R, et al.
Published: (2025-01-01)

The NT-ProBNP Test in Subjects with End-Stage Renal Disease on Hemodialysis Presenting with Acute Dyspnea: Is Knowing Worth the Cost?
by: Shaffer R. S. Mok, et al.
Published: (2013-01-01)

Clinical implication of NT-proBNP to predict mortality in patients with acute type A aortic dissection: a retrospective cohort study
by: Rui Zhang, et al.
Published: (2025-01-01)

Hypertension-Related Gene Polymorphisms of G-Protein-Coupled Receptor Kinase 4 Are Associated with NT-proBNP Concentration in Normotensive Healthy Adults
by: Junichi Yatabe, et al.
Published: (2012-01-01)

Serum NT-Pro-BNP versus Noninvasive Bedside Inotropic Index in Paediatric Shock: A Contest of Myocardial Performance in Response to Fluid Loading
by: Antonius Hocky Pudjiadi, et al.
Published: (2021-01-01)

The Use of N-Terminal-Pro-BNP in Preterm Infants
by: Afif EL-Khuffash, et al.
Published: (2009-01-01)

Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
by: Ericha G Franey, et al.
Published: (2020-01-01)

The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
by: Botey Katamu Benjamin, et al.
Published: (2021-01-01)

Association of preoperative blood biomarkers with postoperative major adverse cardiac events and mortality in major orthopaedic surgery: a systematic review and meta-analysis
by: Lin Lu, et al.
Published: (2025-01-01)

Resistify: A Novel NLR Classifier That Reveals Helitron-Associated NLR Expansion in Solanaceae
by: Moray Smith, et al.
Published: (2025-01-01)

NT-Pro-B-Type Natriuretic Peptide Levels in Infants with Failure to Thrive due to Caloric Deprivation
by: L. B. Mänhardt, et al.
Published: (2010-01-01)

Decrease in platelet count in patients with AKI and its association with major adverse kidney events
by: Ramón Medina-González, et al.
Published: (2024-12-01)

Occurrence and Impact of Gastrointestinal Bleeding and Major Adverse Cardiovascular Events during Sepsis: A 15-Year Observational Study
by: Ming-Shun Hsieh, et al.
Published: (2020-01-01)

Integrating the GRACE Score with the Ceramide Risk Score Enhances the Predictive Accuracy of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Xiaofei Wang, et al.
Published: (2024-12-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
by: Astri Budikayanti, et al.
Published: (2018-01-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
by: Jing Ye, et al.
Published: (2019-01-01)

Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a prospective cohort study
by: Zeyan Liu, et al.
Published: (2025-02-01)

Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region
by: Tian-Jun Zhao, et al.
Published: (2023-01-01)

Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
by: Yan Xiao, et al.
Published: (2020-01-01)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022-01-01)

The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
by: Caroline Barkholt Kamp, et al.
Published: (2025-01-01)

Association between cardiopulmonary bypass duration and early major adverse cardiovascular events after surgical repair of supravalvular aortic stenosis
by: Simeng Zhang, et al.
Published: (2025-01-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
by: Jingrong Yang, et al.
Published: (2025-01-01)

Mediterranean Diet Mediates the Adverse Effect of Depressive Symptomatology on Short-Term Outcome in Elderly Survivors from an Acute Coronary Event
by: Christina Chrysohoou, et al.
Published: (2011-01-01)

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
by: Chien‐Wei Huang, et al.
Published: (2025-02-01)

Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis
by: Arthur Mader, et al.
Published: (2025-01-01)

A disproportionality analysis of FDA adverse event reporting system events for misoprostol
by: Li Yang, et al.
Published: (2025-01-01)

Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes”
by: Bo Shang
Published: (2025-02-01)

The First Harmonic of Radial Pulse as an Early Predictor of Silent Coronary Artery Disease and Adverse Cardiac Events in Type 2 Diabetic Patients
by: Chi-Wei Chang, et al.
Published: (2018-01-01)

Impact of statin use on major adverse cardiovascular events in patients with normal stress myocardial perfusion imaging and elevated coronary artery calcium score
by: Yi Hui To, et al.
Published: (2023-02-01)

Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
by: Alexander R. Lucas, et al.
Published: (2025-02-01)

Visit-to-visit lipid variability on long-term major adverse cardiovascular events: a prospective multicentre cohort from the CORE-Thailand registry
by: Chutithep Teekaput, et al.
Published: (2025-01-01)

Na-TiNT Nanocrystals: Synthesis, Characterization, and Antibacterial Properties
by: Enzo V. H. Agressott, et al.
Published: (2022-01-01)